1. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. (13th April 2022) Authors: Saumoy, Maria; Sánchez-Quesada, Jose Luís; Assoumou, Lambert; Gatell, José Maria; González-Cordón, Ana; Guaraldi, Giovanni; Domingo, Pere; Giacomelli, Andrea; Connault, Jérôme; Katlama, Christine; Masiá, Mar; Ordónez-Llanos, Jordi; Pozniak, Anton; Martínez, Esteban; Podzamczer, Daniel Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 7(2022) Page Start: 1980 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ω-3 supplementation in HIV-1-infected individuals with unsuppressed viral load: cause for caution?. (13th November 2016) Authors: Tort, Olivia; Sánchez-Palomino, Sonsoles; Escribà, Tuixent; Calvo, Carlos; González, Tània; Gatell, José Maria; Sala-Vila, Aleix; Arnedo, Mireia Journal: AIDS Issue: Volume 30:Number 17(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ω-3 supplementation in HIV-1-infected individuals with unsuppressed viral load: cause for caution?. (13th November 2016) Authors: Tort, Olivia; Sánchez-Palomino, Sonsoles; Escribà, Tuixent; Calvo, Carlos; González, Tània; Gatell, José Maria; Sala-Vila, Aleix; Arnedo, Mireia Journal: AIDS Issue: Volume 30:Number 17(2016) Page Start: 2733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗